ATGL increased FFA levels, both ATGL and NEAT1 were shown to be overexpressed in HCC patients, and their roles in promoting hepatocarcinogenesis were confirmed by in vivo xenograft studies [99]. The gene discussed is PNPLA2; the disease is hepatocellular carcinoma.